Achromatopsia
Achromatopsia is a rare hereditary vision disorder affecting approximately 1 in 30,000 newborn babies.
Search results
Achromatopsia is a rare hereditary vision disorder affecting approximately 1 in 30,000 newborn babies.
Cataracts and macular oedema are both associated with inherited sight loss and may respond to treatment.
Support Retina UK this summer by organising a bag packing session at your local supermarket.
Since we were founded in 1976, we have invested more than £16.5million into some of the most pioneering medical research - because of amazing supporters like you.
A research project funded by Retina UK helped pave the way to a new gene therapy that has recently produced encouraging results in two young people with achromatopsia, a condition that causes complete colour-blindness and poor overall vision from birth.
X-linked inheritance means that the faulty gene is located on the X chromosome, the larger of the two sex chromosomes.
Beacon Therapeutics announced positive results from their phase 2 gene therapy trial for X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene.
It was previously believed that female carriers of X-linked inherited retinal diseases (IRDs) like X-linked retinitis pigmentosa (RP and Choroideremia) remained unaffected by sight loss.
ProQR has published the top-line results from its Phase 2/3 “Illuminate” trial of the RNA therapy sepofarsen for Leber congenital amaurosis type 10 caused by a specific mutation in the CEP290 gene.